Business, energy, technology, markets and global industry news from Business News Today

analytical development

PharmaDeviceNews analytical development
Representative image: A scientist reviews sequencing-style quality control data in a modern biopharma lab, illustrating how Oxford Nanopore Technologies and Lonza aim to improve GMP mRNA testing, release workflows and advanced therapy manufacturing.
Pharma & Biotech

Can Oxford Nanopore and Lonza fix the mRNA quality control bottleneck?

Find out how Oxford Nanopore and Lonza’s GMP mRNA QC solution could simplify release testing for next-generation RNA medicines.

Read More
Pharma & Biotech

How Andelyn Biosciences is targeting GMP scale-up challenges in lentiviral vector manufacturing

Cell therapy needs lentiviral vectors, but GMP scale-up remains messy. Andelyn Biosciences is betting standardization can close that gap.

Read More